Get the Stockscreener App
12.29
0.16%
0.02
Bioventus Inc Stock (BVS) Latest News
Osteoarthritis Therapeutics Market Size to Reach USD 24.34 Bn by 2034 - GlobeNewswire Inc.
Connor Clark & Lunn Investment Management Ltd. Buys Shares of 258,756 Bioventus Inc. (NYSE:BVS) - MarketBeat
Segall Bryant & Hamill LLC Invests $4.52 Million in Bioventus Inc. (NYSE:BVS) - MarketBeat
Bioventus (BVS) Matches Q3 Earnings Estimates - MSN
Bioventus Inc (BVS) Shares Up 3.11% on Nov 19 - GuruFocus.com
Joint Pain Injection Market Size, Share, Trends, - openPR
Royce & Associates LP Invests $8.34 Million in Bioventus Inc. (NYSE:BVS) - MarketBeat
Los Angeles Capital Management LLC Acquires Shares of 143,464 Bioventus Inc. (NYSE:BVS) - MarketBeat
Bioventus Inc (BVS) Stock Price Down 2.45% on Nov 12 - GuruFocus.com
Bioventus Inc. (NASDAQ:BVS) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Bioventus reports robust Q3 growth, raises full-year guidance - Investing.com India
Bioventus stock target upgraded, hold buy on strong Q3 performance - Investing.com
Where are the Opportunities in (BVS) - Stock Traders Daily
Bioventus stock target upgraded, hold buy on strong Q3 performance By Investing.com - Investing.com UK
Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... - Yahoo Finance
Bioventus Reports Strong Revenue Growth in Q3 2024 - TipRanks
Bioventus (NYSE:BVS) Shares Gap DownShould You Sell? - MarketBeat
How Are Things Looking For Bioventus Inc (NASDAQ: BVS) For The Short Term? - Stocks Register
U.S. Stock market: Verrica Pharmaceuticals and Marqeta stocks plummet over 37%, while Avalon GloboCare soars 75% in volatile market trend - Business Upturn
Bioventus Inc. Revises Earnings Guidance for the Twelve Months Ending December 31, 2024 - Marketscreener.com
BVSBioventus Inc. Latest Stock News & Market Updates - StockTitan
Bioventus: Q3 Earnings Snapshot - San Francisco Chronicle
Bioventus Inc Reports Q3 2024 Earnings: Revenue Hits $139 Millio - GuruFocus.com
Bioventus (NYSE:BVS) Releases FY24 Earnings Guidance - MarketBeat
Bioventus Reports Third Quarter Financial Results - The Manila Times
Bioventus reports Q3 adjusted EPS 6c, consensus 3c - TipRanks
Viscosupplementation Market Report Analysis, Growth - openPR
Are Medical Stocks Lagging Bioventus (BVS) This Year? - Yahoo Finance
Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Loo - GuruFocus.com
Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Bioventus stock soars to 52-week high, hits $13.65 - Investing.com India
Bioventus stock soars to 52-week high, hits $13.65 By Investing.com - Investing.com South Africa
Bioventus (BVS) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Should Bioventus Stock Be in Your Portfolio Pre-Q3 Earnings? - MSN
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024 - The Manila Times
Long Term Trading Analysis for (BVS) - Stock Traders Daily
Bioventus Surges 73% in Three Months: Time to Buy the Stock? - MSN
Bioventus (NYSE:BVS) Reaches New 1-Year HighStill a Buy? - MarketBeat
Bioventus stock soars to 52-week high, hits $13.14 - Investing.com India
SG Americas Securities LLC Lowers Stock Position in Bioventus Inc. (NYSE:BVS) - Defense World
Are Medical Stocks Lagging ChromaDex (CDXC) This Year? - Yahoo Finance
Bioventus stock soars to 52-week high of $12.43 amid growth By Investing.com - Investing.com South Africa
Bioventus (NYSE:BVS) Reaches New 52-Week HighStill a Buy? - MarketBeat
Bioventus stock soars to 52-week high of $12.43 amid growth - Investing.com Australia
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):